Journal of HIV/AIDS Research and Antiviral Therapy (JHARAT) predominantly encourages submission of manuscripts related to Antiviral, Mechanisms of Action of Antiviral Agents, Antiviral Targeting, Clinical aspects types of the treatment for early detection and diagnosis.
Journal of HIV/AIDS Research and Antiviral Therapy is a Peer-Reviewed, Open Access Journal that aims to publish Scholarly Articles describing clinical examinations, investigative studies and practices related to ethology, diagnosis, treatment and prevention of HIV/AIDS Research and Antiviral Therapy
All the articles submitted to JHARAT subject to rigorous double-blind peer review process under the guidance of an international editorial board consisting of a distinguished team of General medicine and Clinical Practice researchers and reviewers.
Antiretroviral therapy for HIV infection has been available since the introduction and approval of zidovudine in 1986. At the time of writing, nearly 20 drugs in 4 classes and a number of immunomodulatory and other adjunctive agents are available for the treatment of HIV infection in the United States. The use of combinations of antiretroviral drugs to provide potent antiretroviral therapy (ART) has dramatically impacted the morbidity and mortality due to HIV infection and AIDS. However, clinicians are increasingly faced with challenges in the selection and management of ART regimens, including the choice of most efficacious therapy, the avoidance of drug toxicity, and the impact of drug-drug interactions. Although the introduction of viral genotyping and combination-therapy pharmacokinetic data has provided some guidance, the investigation of host genetic factors that impact both the efficacy and toxicity of ART may also aid in selecting the best regimen for individual patients.